Report an error

Spotted something inaccurate in “Practical 177Lu-PSMA Dosimetry Advances Support Personalized Prostate Cancer Radioligand Therapy”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.